PDL BioPharma (PDLI)

3.18 +0.07 (2.25%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/8/19 *Est.)

Latest Headlines

Form 4 PDL BIOPHARMA, INC. For: Dec 31 Filed by: MCLAUGHLIN JOHN PETER January 9, 2019 10:27 AM - SEC Filing Form 8-K PDL BIOPHARMA, INC. For: Jan 07 January 7, 2019 10:27 AM - SEC Filing Form 4 PDL BIOPHARMA, INC. For: Dec 27 Filed by: Monnet Dominique December 28, 2018 6:32 PM - SEC Filing Form 4 PDL BIOPHARMA, INC. For: Dec 27 Filed by: GARCIA PETER S December 28, 2018 6:31 PM - SEC Filing Form 4 PDL BIOPHARMA, INC. For: Dec 27 Filed by: Stone Christopher Lewis December 28, 2018 6:30 PM - SEC Filing Form 4 PDL BIOPHARMA, INC. For: Dec 27 Filed by: MCLAUGHLIN JOHN PETER December 28, 2018 6:29 PM - SEC Filing Form 8-K PDL BIOPHARMA, INC. For: Dec 21 December 21, 2018 6:03 AM - SEC Filing Report: Exploring Fundamental Drivers Behind Tesla, Nordson, Paycom Software, PDL BioPharma, Corcept Therapeutics, and Willis Towers Watson Public — New Horizons, Emerging Trends, and Upcoming Devel November 30, 2018 8:15 AM - Globe NewsWire Form 8-K PDL BIOPHARMA, INC. For: Nov 29 November 29, 2018 6:04 AM - SEC Filing Form 8-K PDL BIOPHARMA, INC. For: Nov 27 November 27, 2018 6:05 AM - SEC Filing PDL BioPharma to Present at the 30th Annual Piper Jaffray Healthcare Conference November 19, 2018 9:00 AM - PR NewsWire Form 10-Q PDL BIOPHARMA, INC. For: Sep 30 November 7, 2018 4:08 PM - SEC Filing PDL BioPharma (PDLI) Reports Q3 EPS of $0.18 November 6, 2018 5:16 PM - StreetInsider Form 8-K PDL BIOPHARMA, INC. For: Nov 06 November 6, 2018 4:10 PM - SEC Filing PDL BioPharma Reports Third Quarter 2018 Financial Results November 6, 2018 4:05 PM - PR NewsWire PDL BioPharma to Announce Third Quarter Financial Results on November 6, 2018 October 31, 2018 4:05 PM - PR NewsWire Full Article List